 <h1>Congratulations! 🎉 </h1>
    <p style="color:#637381;">All done! You’ve completed another milestone.</p>

To continue, enter your details to log in.

We’ve sent a 6‑digit code to #MAIL_ADDRESS#\nPlease check your inbox or spam folder and enter the code below to continue.

Verification code sent

Thank you for the payment. You can now access {collectionName} by simply clicking the button below.

Yes, you’ve successfully ordered! 🎉

Unlock This Exclusive Course

It seems that your email address is not currently on the authorized access list. Please ensure you are using the email address that was invited, or contact the content owner for assistance.

Verification Required for Access

Core Principles of Q2(R2) and Q14

Topic: Relationship between Q2(R2) and Q14 lifecycle approach

What is your course about?

SLIDE 2 — Concept Simplified

Practical Application and Compliance Risks

SLIDE 1 — Opening Hook

SLIDE 3 — Case Study

SLIDE 4 — Practical Application

10-POINT KEY AUDIT CHECKLIST

Copy of 10-POINT KEY AUDIT CHECKLIST

Quiz

FIVE MULTIPLE CHOICE QUESTIONS

Part A — Quiz (3 in-slide questions)

Decision point / Compliance dilemma

Risk indicators (stop and check)

Objective

Survey and Feedback

Part B — Reflection

Part C — Summary (Top 5 Takeaways)

Are you ready to master the latest regulatory expectations for analytical procedures. Welcome to "Implementing the ICH Q2(R2) and Q14 Analytical Procedure Lifecycle," a comprehensive course designed to bridge the gap between analytical development, validation, and routine monitoring.

Are you ready to master the latest regulatory expectations for analytical procedures? Welcome to "Implementing the ICH Q2(R2) and Q14 Analytical Procedure Lifecycle," a comprehensive course designed to bridge the gap between analytical development, validation, and routine monitoring. With the pharmaceutical industry shifting towards a more integrated lifecycle approach, understanding the nuances of ICH Q2(R2) and ICH Q14 is no longer optional—it is essential for compliance and operational excellence. 

This course demystifies the core principles of both guidelines, explaining how they map directly onto the three critical stages of the analytical procedure lifecycle: design and development, performance qualification, and ongoing performance verification. You will explore the fundamental differences between the mandatory validation requirements of Q2(R2) and the optional, enhanced approaches offered by Q14. 

Beyond theory, this course dives deep into practical application and compliance risks. We will analyze real-world case studies, identify warning signs of disconnected validation, and equip you with a robust 10-point key audit checklist to ensure your validation packages are complete, lifecycle-coherent, and inspection-ready. Whether you are looking to eliminate the legacy "just hit the numbers" mindset or seeking to leverage regulatory flexibility for smoother post-approval change management, this course provides the actionable insights you need. Join us to elevate your analytical procedure lifecycle strategy, ensure patient safety, and maintain impeccable product quality.

Implementing the ICH Q2(R2) and Q14 Analytical Procedure Lifecycle

<div class="simple-box-wrapper">
    <div class="simple-box">
        <div class="column">
            <p>The pharmaceutical and biopharmaceutical industries are undergoing a critical paradigm shift in how analytical procedures are developed, validated, and maintained. For years, the prevailing mindset under the legacy ICH Q2(R1) guideline was often reduced to a "just hit the numbers" approach, where validation was treated as an isolated, check-the-box exercise. However, this disconnected methodology now carries significant inspection and quality risks, as regulatory agencies increasingly scrutinize validation reports that lack a logical linkage to specification widths or the method's intended use. Regulatory expectations have evolved to demand a comprehensive, lifecycle-oriented approach that ensures analytical procedures remain fit for their intended purpose from initial design through routine commercial application. This course addresses the urgent need to transition away from outdated validation habits by providing a thorough understanding of the newly integrated ICH Q2(R2) and ICH Q14 guidelines, assuming no prior knowledge of the Q14 framework.</p>

<p>Throughout this program, professionals across Quality Assurance, Quality Control, Validation, Regulatory Affairs, Manufacturing, and Engineering will explore the fundamental relationship between the mandatory validation requirements of Q2(R2) and the optional enhanced development approaches offered by Q14. The curriculum systematically breaks down the three critical stages of the analytical procedure lifecycle: design and development, performance qualification, and ongoing performance verification. By analyzing real-world case studies, identifying warning signs of disconnected validation, and utilizing a structured 10-point audit checklist, participants will learn how to establish documented traceability and justify acceptance criteria based on the Analytical Target Profile (ATP) and established conditions. Ultimately, this training equips industry professionals with the strategic knowledge required to mitigate compliance dilemmas, optimize post-approval change management, and ensure robust ongoing performance verification that safeguards both product quality and patient safety.</p>
        </div>
    </div>
</div>
